Atlas Trials

Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

Clinical trial NCT03961867 · UNKNOWN

Trial details

NCT number
NCT03961867
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2020-09-15
Primary completion
2022-09-01
Enrollment
440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.